<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03299972</url>
  </required_header>
  <id_info>
    <org_study_id>P59723</org_study_id>
    <nct_id>NCT03299972</nct_id>
  </id_info>
  <brief_title>Resistance Exercise and Whey Protein Supplementation to Combat Age-related Sarcopenia</brief_title>
  <official_title>Effects of 12 Weeks Resistance Exercise and Whey Protein Supplementation on Multiple Indices of Sarcopenia in Older Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coventry University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospitals Coventry and Warwickshire NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Coventry University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomised, double-blind, placebo-controlled, parallel groups trial is to
      investigate the effects of 12 weeks resistance exercise and whey protein supplementation on
      multiple markers of sarcopenia in older men.

      Generally healthy, retired men aged 60-80 years will be recruited (n = 52 in total, n = 13
      per group). Participants will be randomised to either: a) control group [placebo only], b)
      whey protein supplement group, c) resistance exercise + placebo group or d) resistance
      exercise + whey protein supplementation group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With demographics indicating that the world's population aged &gt;60 years will increase from
      600 million reported in 2000, to &gt;2 billion by 2050, there is an increasing interest in
      health issues related to ageing. One area of particular interest is sarcopenia, defined as
      the progressive loss of muscle mass, strength and physical function as a consequence of
      ageing. Sarcopenia has been associated with an increase in cardiovascular disease, poor
      metabolic and cognitive function, reduced quality of life and early mortality. Studies have
      reported beneficial effects of both resistance exercise and increasing protein intake
      independently and in combination on markers of sarcopenia (mostly increases in muscle mass,
      strength and physical function). However, little is known about the effects of combined
      intervention on chronic inflammation as well as metabolic, cognitive and endocrine function.
      This randomised, double-blind, placebo-controlled, parallel groups trial will investigate
      these, alongside assessing the effects of combined intervention on total lean tissue mass,
      muscular strength and functional performance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 27, 2017</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total lean tissue mass (kg)</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>Measured via BODPOD (air displacement plethysmography)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Handgrip strength (kg)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isotonic Strength (kg)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endurance (Six Minute Walk Test)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Physical Performance Battery (SPPB)</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>Balance, Gait speed and time to sit and stand from a chair 5 times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Function - Cambridge Cognition Neuropsychological Testing Battery</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: Insulin-Like Growth Factor 1 (IGF-1)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: Myostatin</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: C-reactive Protein (CRP)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: Glycated Haemoglobin (HbA1c)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary: Dehydroepiandrosterone (DHEA)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary: Cortisol</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: Tumor necrosis factor alpha (TNF-Î±)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Habitual Physical Activity</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>Accelerometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: Insulin Resistance (HOMAR-IR)</measure>
    <time_frame>0 to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Metabolic Rate</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>Indirect Calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy expenditure (over 24 hours)</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>24 hour Whole Body Calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substrate Oxidation During Rest, Sleep and Exercise</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>24 hour Whole Body Calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleeping Metabolic Rate</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>24 hour Whole Body Calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interstitial Glucose</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>24 Hour Continuous Glucose Monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: Low-Density Lipoprotein (LDL-C)</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>LDL-C</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: High-Density Lipoprotein (HDL-C)</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>HDL-C</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical: Triglycerides</measure>
    <time_frame>0 to 12 weeks</time_frame>
    <description>Triglycerides</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Muscle Atrophy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Whey Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance Exercise + Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance Exercise + Whey Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey Protein</intervention_name>
    <description>25 g of whey protein supplementation twice daily (breakfast and lunch)</description>
    <arm_group_label>Whey Protein</arm_group_label>
    <arm_group_label>Resistance Exercise + Whey Protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>23.75 g of placebo powder twice daily (breakfast and lunch)</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Resistance Exercise + Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance Exercise</intervention_name>
    <description>60 minutes of resistance exercise twice a week</description>
    <arm_group_label>Resistance Exercise + Placebo</arm_group_label>
    <arm_group_label>Resistance Exercise + Whey Protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Retired Men aged 60-80 years

          -  Body Mass Index 18.5-30 kg/m2

          -  Not participated in resistance exercise within the last 6 months

          -  Free from musculoskeletal injury

        Exclusion Criteria:

          -  Retired Men aged &lt;60 or &gt;80 years

          -  Current smokers, or ex-smokers ceasing &lt;6 months ago

          -  Body Mass Index &lt;18.5 and &gt;30 kg/m2

          -  Currently participating in resistance exercise regularly (within last 6 months)

          -  Not weight stable and/or looking to start a weight loss programme

          -  Individuals participating in another research project (within the last 6 months)
             involving dietary and/or exercise intervention

          -  Existing or past medical history of vascular disease, cancer, diabetes, neurological,
             kidney, pulmonary, digestive (Coeliac disease), thyroidal disease, osteoporosis or
             history of falls

          -  Currently taking protein/amino acid supplements regularly

          -  Currently prescribed non-steroidal anti-inflammatory medication, hormone replacement
             therapy (HRT), diabetic medication, beta-blockers

          -  Uncontrolled blood pressure (Blood pressure &gt;160/100 mmHg)

          -  Self-reported lactose intolerant or allergic to wheat or potatoes

          -  Individuals with a pacemaker

          -  Neuromuscular disorders or injuries
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derek Renshaw, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Coventry University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Hattersley, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hosptials Coventry and Warwickshire NHS Trust</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Duncan, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Coventry University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Corbin Griffen, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Coventry University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Corbin Griffen, MSc</last_name>
    <phone>024 7765 8075</phone>
    <email>griffenc@uni.coventry.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Derek Renshaw, PhD</last_name>
    <phone>024 7765 8075</phone>
    <email>ab9598@coventry.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Coventry University</name>
      <address>
        <city>Coventry</city>
        <state>West Midlands</state>
        <zip>CV1 5FB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corbin Griffen, MSc</last_name>
      <email>griffenc@uni.coventry.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Derek Renshaw, PhD</last_name>
      <email>ab9598@coventry.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2017</study_first_submitted>
  <study_first_submitted_qc>September 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2017</study_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Coventry University</investigator_affiliation>
    <investigator_full_name>Corbin Griffen</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>Resistance exercise</keyword>
  <keyword>Protein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

